Evidence map›Paper›PMID 31578268›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance.

Rafael M Rezende, Brenda N Nakagaki, Thais G Moreira, Juliana R Lopes, Chantal Kuhn, Bruna K Tatematsu, Selma Boulenouar, Amir-Hadi Maghzi, Stephen Rubino, Gustavo B Menezes and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Rafael M RezendeAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and rmachadorezende@bwh.harvard.edu.
Brenda N NakagakiAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.ORCID 0000-0002-5597-2726
Thais G MoreiraAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Juliana R LopesAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Chantal KuhnAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Bruna K TatematsuAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Selma BoulenouarAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Amir-Hadi MaghziAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Stephen RubinoAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Gustavo B MenezesCenter for Gastrointestinal Biology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil.
Tanuja ChitnisAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Howard L WeinerAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and.
Brigham and Women's Hospital · USUniversidade Federal de Minas Gerais · BR

Funding

MECHANISMS OF THE INDUCTION OF ORAL TOLERANCER01AI043458 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WEINER, HOWARD L · 1998 to 2015
$5.0M
NIAID NIH HHS R01 AI043458
6 · The paper itself

Abstract

Oral tolerance is defined as the specific suppression of cellular and/or humoral immune responses to an Ag by prior administration of the Ag through the oral route. Although the investigation of oral tolerance has classically involved Ag feeding, we have found that oral administration of anti-CD3 mAb induced tolerance through regulatory T (Treg) cell generation. However, the mechanisms underlying this effect remain unknown. In this study, we show that conventional but not plasmacytoid dendritic cells (DCs) are required for anti-CD3-induced oral tolerance. Moreover, oral anti-CD3 promotes XCL1 secretion by small intestine lamina propria γδ T cells that, in turn, induces tolerogenic XCR1

Indexed as

Administration, OralAnimalsCD3 ComplexCell MovementChemokines, CDendritic CellsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleGene Knockout TechniquesGenes, T-Cell Receptor deltaImmune ToleranceIntestinal MucosaIntraepithelial LymphocytesLymph NodesMaleCD3 ComplexChemokines, CMuromonab-CD3Myelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide FragmentsXcl1 protein, mouse

Identifiers

PMID31578268
PMCPMC6832869
OpenAlexW2977475880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.